Axogen shares climbed 29% after quarterly sales and adjusted earnings rose and management lifted its full-year revenue forecast.
Why Axogen Stock Jumped 29% Today
Axogen Inc. (NASDAQ: AXGN) shares climbed 29% to $48.15 after reporting stronger quarterly results and raising its full-year revenue outlook. The stock was trading at that price by early afternoon during regular trading hours. The report gives investors stronger sales results and a higher forecast for the business.
What Axogen Inc. Does
Axogen develops and sells surgical products used to repair damaged peripheral nerves, which carry signals between the brain and the rest of the body. More revenue from these products points to stronger business demand.
Axogen Third Quarter Results And Outlook
Revenue rose 26.2% year over year to $75.8 million, while adjusted net income was $13.1 million, or $0.21 per share. Adjusted net income uses company-defined exclusions, so it differs from standard reported profit. Axogen raised its 2026 revenue outlook, meaning management’s sales forecast, to at least $290 million.
Axogen Shares Trade Heavily Today
Trading volume reached about 6.5 million shares, equal to about six times the usual pace for this hour. That shows unusually strong participation in the move.
Quick Financial Overview
Axogen is a mid-cap, meaning its stock market value falls in the middle range, with a $2.83B total value for its shares. It reported $111.4M in cash, cash equivalents, and short-term investments as of June 30, 2026; cash equivalents are holdings readily turned into cash. That balance predates the latest quarterly results.
Axogen Net Income
Axogen reported net income of $2.3 million, compared with $0.7 million a year earlier. This is the standard profit measure before company-defined adjustments, which can make adjusted earnings differ.
Axogen Latest Cash And Investments
As of September 30, 2026, Axogen had $350.1 million in cash, near-cash holdings, cash set aside for specific uses, and investments. Because the total includes funds set aside for specific uses, it should not all be treated as freely available spending money.
Axogen Share Offering Risk
Axogen has a recent offering-related filing, a document connected to a potential share sale. Selling additional shares can dilute current holders, meaning each holder owns a smaller percentage of the company.
Axogen Stock Posts Its Biggest Move In A Year
Axogen traded around the $40 level a month ago before today’s jump carried it higher. Shares reached the $50 level by late morning and stayed at or above the $45 level. Today was the biggest daily move in the last year, making this more than a routine rebound.
Trading Perspective
Axogen remains below the $55 level, its high area over the past year. Clearing that area would extend the recovery beyond its earlier peak.
The approximate bottom of today’s opening gap, the price space left by the higher open, is the $35 level. A return there would erase that opening advance rather than guarantee a rebound.
Conclusion
Axogen’s next quarterly earnings report will test whether customers keep buying at a pace that supports management’s expectations; its date has not been announced here. Continued growth would strengthen the business case behind the rally, while slower demand would leave less room for disappointment.
This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.
Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.
Check out our quick startup guide for new traders!
- How to Read Stock Charts: A Guide for Beginners
- Trading Plan: 6 Steps to Create One
- How To Create a Stock Watchlist
Ready to build your watchlists? Check out these curated lists:
Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

